Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Particpants were divided into groups based on doses of rosuvastatin and were assessed and for CPK, LDL and AST levels
Epistemonikos ID: 1a681cf6a4bc18541a20dc9d1aed3f6d45d46276
First added on: Apr 05, 2025